Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FQJW6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 100% obligated
- $2,493.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Fasenra pen 30 mg/ml. The award, dated January 27, 2026, is firm fixed-price with an ultimate completion date of January 28, 2026, and carries no set-aside designation. DMS Pharmaceutical Group will perform at its Park Ridge facility. This delivery order represents a routine pharmaceutical supply transaction within DLA's broader medical supply chain operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC designated as contract SPE2DR, valued at $499,999,999 with a completion date of December 31, 2036, enabling the company to serve as a critical pharmaceutical supplier for DoD medical operations. The company's portfolio includes branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, demonstrating its capacity to fulfill diverse pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQJW6?
SPE2DR26FQJW6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FQJW6 worth?
The government has obligated $2,494 on SPE2DR26FQJW6.
Is contract SPE2DR26FQJW6 an order under another contract?
Yes. SPE2DR26FQJW6 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJW6 competed?
The extent of competition for SPE2DR26FQJW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award